Article Versions Notes

Poznański P, Augustyniak-Bartosik H, Magiera-Żak A, Skalec K, Jakuszko K, Mazanowska O, Janczak D, Krajewska M, Kamińska D. Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients. Viruses. 2022; 14(10):2224. https://doi.org/10.3390/v14102224

Poznański, Paweł, Hanna Augustyniak-Bartosik, Anna Magiera-Żak, Karolina Skalec, Katarzyna Jakuszko, Oktawia Mazanowska, Dariusz Janczak, Magdalena Krajewska, and Dorota Kamińska. 2022. "Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients" Viruses 14, no. 10: 2224. https://doi.org/10.3390/v14102224

Poznański, P., Augustyniak-Bartosik, H., Magiera-Żak, A., Skalec, K., Jakuszko, K., Mazanowska, O., Janczak, D., Krajewska, M., & Kamińska, D. (2022). Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients. Viruses, 14(10), 2224. https://doi.org/10.3390/v14102224